The Asia Pacific NeuroAIDS Consortium (APNAC) Study

Not Applicable

Completed

• Conditions: HIV; HIV-related neurological diseases; Infection - Acquired immune deficiency syndrome (AIDS / HIV); Neurological - Other neurological disorders

• Registration Number: ACTRN12605000493640
• Lead Sponsor: ational Institute of Mental Health and National Institute of Neurological Disorders and Stroke

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-09-23
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 600

Inclusion Criteria

Patients are HIV infected.

Exclusion Criteria

No exclusion criteria

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. To determine the prevalence of HIV-related neurocognitive impairment and ADC at the APNAC-10 sites[];2. To determine the prevalence of symptomatic peripheral sensory neuropathy at the APNAC-10 sites[];3. To determine the prevalence of central nervous system opportunistic infections and tumours at the APNAC-10 sites[]